Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15820-15829
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15820
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Patient flow chart of the main cohort. CRT: Chemoradiotherapy; CT: Chemotherapy; PE: Pulmonary embolism; RT: Radiotherapy; TEM: Transanal endoscopic microsurgery.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Cumulative hazards estimates. A: Local relapse in the main cohort; B: Distant relapse in the main cohort; C: Local relapse in the external reference cohort (note: complete- and intermediate-responders overlap); D: Distant relapse in the external reference cohort.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Kaplan-Meier estimates. A: Disease-free survival in the main cohort; B: Overall survival in the main cohort; C: Disease-free survival in the external reference cohort; D: Overall survival in the external reference cohort.
  • Citation: García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. World J Gastroenterol 2014; 20(42): 15820-15829
  • URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15820.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15820